Startup Aims to Treat Muscular Dystrophy with CRISPR – MIT Technology Review
MIT Technology Review |
Startup Aims to Treat Muscular Dystrophy with CRISPR
MIT Technology Review A foundation representing boys dying from muscular dystrophy says it will try to cure the disease using CRISPR, a breakthrough method of correcting DNA. CureDuchenne, a patient charity based in Newport Beach, California, says it will spend $5 million … Exonics to use CRISPR in an effort to treat majority of DMD boys CureDuchenne Ventures Commits $5M to Startup with CRISPR-Based DMD Therapy Nonprofit Seeds Exonics to Fund Push For CRISPR Duchenne Treatment |
